@gabrielavpn21's GLP-1 for PCOS claims, fact-checked

What does this video actually claim?

Gabriela shows before-and-after photos suggesting GLP-1 medication improved her appearance, specifically mentioning PCOS in her hashtags. She's essentially claiming that what people call "Ozempic face" (the gaunt, aged look some report) isn't necessarily bad.

The video is light on specific medical claims. She includes a disclaimer about personal experience and consulting doctors. But the hashtags tell the real story: she's connecting GLP-1 drugs to PCOS management and women's health.

Does GLP-1 medication actually help with PCOS?

The evidence is promising but limited. A 2022 systematic review by Elkind-Hirsch found that GLP-1 receptor agonists improved multiple PCOS symptoms including weight, insulin resistance, and hormonal profiles.

The strongest data comes from small studies. Frøssing et al. (2018) showed liraglutide 1.8mg daily led to 4.5kg weight loss over 26 weeks in women with PCOS, compared to 0.5kg with placebo. Participants also saw improved menstrual regularity and reduced testosterone levels.

But here's what Gabriela doesn't mention: these weren't massive studies. We're talking 70-80 participants, not the thousands seen in diabetes trials. The PCOS evidence is encouraging, not definitive.

What about the 'Ozempic face' angle?

This is where things get tricky. "Ozempic face" isn't a medical term. It describes facial volume loss that can occur with rapid weight loss from any cause.

The STEP trials documented weight loss averaging 14.9% with semaglutide 2.4mg (Wilding et al., NEJM 2021). When you lose that much weight quickly, facial fat loss is normal. Whether that looks good or bad is subjective.

Gabriela's photos suggest she's happy with her results. But her experience doesn't change the biological reality: significant weight loss typically means facial volume loss. Some people love the sharper facial definition. Others hate it.

What did she get right and wrong?

Credit where it's due: Gabriela included a proper disclaimer about individual experiences and medical consultation. That's more responsible than most health influencers.

But the video lacks important context. She doesn't mention that GLP-1 drugs aren't FDA-approved for PCOS treatment. She's using medication off-label, which is legal but worth disclosing.

The bigger issue is the implication that "Ozempic face" concerns are overblown. For some people, especially older adults, facial volume loss can be significant and distressing. Dismissing those concerns isn't helpful.

What should you actually know about GLP-1 drugs and PCOS?

The research suggests potential benefits, but it's early-stage evidence. Most studies used liraglutide, not the semaglutide or tirzepatide that dominate social media discussions.

PCOS management typically starts with lifestyle changes and metformin. GLP-1 drugs might be an option if first-line treatments aren't sufficient, but they're not standard care.

If you're considering this route, expect thorough screening. Good physicians will check for contraindications, discuss side effects beyond facial changes (nausea affects 20-30% of users), and monitor your response carefully.